Elicio Therapeutics's total assets for Q1 2026 were $22.69M, a decrease of -12.27% from the previous quarter. ELTX total liabilities were $24.13M for the fiscal quarter, a -0.41% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.